| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 4 buys and 6 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2021 | Crowley John F67 | Chairman &CEO | Sale+OE | 37,000 | $10.03 | $371,047.10 | -4.2% | +22.9% | +21.1% | |
| Aug 5, 2021 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 21,028 | $10.02 | $210,671.12 | -4.4% | +22.9% | +21.1% | |
| Aug 2, 2021 | Whitman Burke W50 | Director | Buy | 1,500 | $9.28 | $13,920.00 | +2.5% | +22.6% | +6.0% | |
| Jul 12, 2021 | Crowley John F67 | Chairman &CEO | Sell | 14,885 | $9.31 | $138,652.29 | -1.7% | +26.8% | +21.6% | |
| Jul 1, 2021 | Whitman Burke W50 | Director | Buy | 1,500 | $9.60 | $14,400.00 | +2.6% | -2.2% | +9.3% | |
| Jun 15, 2021 | Crowley John F67 | Chairman &CEO | Sale+OE | 22,000 | $10.26 | $225,632.00 | -2.4% | +8.9% | -20.9% | |
| Jun 7, 2021 | Crowley John F67 | Chairman &CEO | Sale+OE | 29,500 | $10.01 | $295,191.75 | -3.3% | +12.9% | -16.4% | |
| Jun 7, 2021 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 10,514 | $10.01 | $105,207.29 | -2.2% | +12.9% | -16.4% | |
| Jun 1, 2021 | Whitman Burke W50 | Director | Buy | 1,500 | $9.24 | $13,861.20 | +3.3% | +18.3% | -20.1% | |
| May 25, 2021 | Bleil Lynn Dorsey | Director | Buy | 28,605 | $8.74 | $250,007.70 | +131.8% | +23.5% | -13.1% |